Clinical research progress in autologous hematopoietic stem cell transplantation for malignant lymphoma treatment / 中国肿瘤临床
Chinese Journal of Clinical Oncology
;
(24): 1-7, 2015.
Article
in Chinese
| WPRIM
| ID: wpr-462656
ABSTRACT
High-dose therapy (HDT) combined with autologous hematopoietic stem cell transplantation (AHSCT) is a standard treatment for relapsed or refractory aggressive lymphoma. However, the role of HDT/AHSCT in the first-line treatment of lymphoma remains controversial, and related issues about its application in different subtypes of lymphoma should be addressed. This article brief-ly reviewed the clinical progress in AHSCT for malignant lymphoma treatment.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Clinical Oncology
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS